INIS
patients
100%
units
37%
hospitals
29%
kidneys
26%
indonesia
24%
surgery
24%
mortality
24%
levels
22%
comparative evaluations
21%
therapy
19%
diseases
18%
risks
17%
covid-19
16%
management
16%
pain
14%
pneumonia
14%
nephrectomy
13%
coronaviruses
12%
control
11%
data
10%
interventions
9%
inflammation
9%
failures
9%
fluids
8%
ventilation
8%
values
8%
antibiotics
8%
adults
7%
plasma
7%
injuries
7%
volume
7%
pseudomonas
6%
anesthesia
6%
assessments
6%
blood
6%
organs
5%
transplants
5%
oxygen
5%
klebsiella
5%
administration
5%
Keyphrases
Intensive Care Unit
36%
Indonesia
27%
COVID-19
21%
Randomized Controlled Trial
16%
Critically Ill Patients
15%
Referral Hospital
15%
Jakarta
13%
Quadratus Lumborum Block
12%
Carbapenem-susceptible
12%
Critically Ill
11%
Laparoscopic Partial Nephrectomy
10%
Pseudomonas Aeruginosa (P. aeruginosa)
9%
Sepsis
8%
High Risk
8%
COVID-19 Patients
8%
Continuous Epidural Infusion
8%
Kidney Transplantation
8%
Septic Shock
8%
Postoperative Analgesia
7%
Risk Factors
6%
28-day Mortality
6%
Therapeutic Plasma Exchange
6%
Severe Pneumonia
6%
Intubated
6%
Mortality Rate
5%
Klebsiella Pneumoniae (K. pneumoniae)
5%
Interleukin-6
5%
Acute Kidney Injury
5%
Pneumonia Patients
5%
Donor Nephrectomy
5%
Indonesian
5%
Critically Ill COVID-19 Patients
5%
Medicine and Dentistry
Intensive Care Unit
29%
Kidney Transplantation
16%
COVID-19
15%
Randomized Controlled Trial
14%
Carbapenem
13%
Nephrectomy
13%
Patient Referral
12%
Hemodynamic
11%
Sepsis
9%
Pseudomonas aeruginosa
9%
Epidural Analgesia
9%
Epidural Anesthesia
8%
Septic Shock
8%
Analgesia
8%
Digestive System Surgery
7%
Living Donor
7%
Postoperative Analgesia
7%
Interleukin 6
6%
Bupivacaine
6%
Plasma Exchange
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Acute Kidney Injury
5%
Kidney Graft
5%
Klebsiella pneumoniae
5%
Infection
5%
